Malaria transmission-blocking vaccines.
Antibodies to surface proteins of the sexual stages of Plasmodium falciparum block completely the transmission of these malaria parasites. Transmission-blocking vaccines therefore represent a powerful and novel approach to controlling the spread of this lethal disease.
Molecular Vaccine Section, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
D C
DC
Kaslow
I C
IC
Bathurst
P J
PJ
Barr
D000818:Animals; D005260:Female; D006801:Humans; D008288:Malaria / Q000517:prevention & control* / Q000635:transmission; D008297:Male; D010963:Plasmodium falciparum / Q000276:immunology*; D015800:Protozoan Proteins / Q000235:genetics / Q000276:immunology; D016052:Protozoan Vaccines / Q000276:immunology*; D015003:Yeasts / Q000235:genetics
D015800:Protozoan Proteins; D016052:Protozoan Vaccines